{"id":36782,"date":"2025-02-07T09:21:38","date_gmt":"2025-02-07T09:21:38","guid":{"rendered":"https:\/\/new.igihe.com\/french\/Le-Rwanda-engage-des-discussions-avec-Pharco-Pharmaceuticals-36782\/"},"modified":"2025-02-07T20:27:51","modified_gmt":"2025-02-07T20:27:51","slug":"Le-Rwanda-engage-des-discussions-avec-Pharco-Pharmaceuticals","status":"publish","type":"post","link":"https:\/\/new.igihe.com\/french\/Le-Rwanda-engage-des-discussions-avec-Pharco-Pharmaceuticals\/","title":{"rendered":"Le Rwanda engage des discussions avec Pharco Pharmaceuticals"},"content":{"rendered":"<p>Pharco Pharmaceuticals, fond\u00e9e en 1983 par le Dr. Hassan Abbas Helmy, est l&#8217;une des plus grandes entreprises pharmaceutiques d&#8217;\u00c9gypte. L&#8217;entreprise fabrique des m\u00e9dicaments sous la marque Pharco et distribue ses produits dans plus de 50 pays \u00e0 travers le monde. En 2019, l&#8217;entreprise a r\u00e9alis\u00e9 des ventes atteignant 750 millions de bo\u00eetes de m\u00e9dicaments. Parmi ses produits, on retrouve l&#8217;Acne Zinc, utilis\u00e9 pour traiter les probl\u00e8mes de peau, l&#8217;Alambuphine, un m\u00e9dicament contre la fi\u00e8vre, et l&#8217;Alfatral, destin\u00e9 au traitement des infections urinaires, entre autres.<\/p>\n<p>Ce jeudi 6 f\u00e9vrier 2025, le Pr\u00e9sident Paul Kagame a accueilli une d\u00e9l\u00e9gation de Pharco Pharmaceuticals, dirig\u00e9e par la Directrice G\u00e9n\u00e9rale, Dr. Sherine Abbas Helmy. Les discussions ont \u00e9t\u00e9 suivies par le ministre de la Sant\u00e9, Dr. Sabin Nsanzimana. Les entretiens ont principalement port\u00e9 sur les opportunit\u00e9s de coop\u00e9ration entre le Rwanda et l&#8217;entreprise dans les domaines de la sant\u00e9 et de la production pharmaceutique.<\/p>\n<p>Avant de rencontrer le Pr\u00e9sident Kagame, Dr. Sherine Abbas Helmy et sa d\u00e9l\u00e9gation ont \u00e9chang\u00e9 avec le Directeur G\u00e9n\u00e9ral de l&#8217;Agence rwandaise de d\u00e9veloppement (RDB), Jean-Guy Afrika. La RDB a indiqu\u00e9 que les discussions ont port\u00e9 sur les possibilit\u00e9s d&#8217;\u00e9largir l&#8217;approvisionnement en m\u00e9dicaments essentiels au Rwanda, de mener des essais cliniques locaux et de mettre en place des infrastructures pour la production de m\u00e9dicaments dans le pays.<\/p>\n<p>L&#8217;objectif est de garantir des services de sant\u00e9 de qualit\u00e9 et modernes pour les citoyens rwandais tout en attirant davantage de patients \u00e9trangers, r\u00e9duisant ainsi la d\u00e9pendance \u00e0 l&#8217;\u00e9gard des soins m\u00e9dicaux \u00e0 l&#8217;\u00e9tranger.<\/p>\n<p>Ce projet de collaboration avec Pharco Pharmaceuticals pourrait s&#8217;ajouter \u00e0 d&#8217;autres initiatives en cours au Rwanda, notamment la construction d&#8217;une usine de vaccins en partenariat avec BioNTech, une soci\u00e9t\u00e9 allemande.<\/p>\n<p>En novembre dernier, l&#8217;Autorit\u00e9 rwandaise de d\u00e9veloppement (RDB) avait \u00e9galement sign\u00e9 un accord avec Bio Usawa Inc pour \u00e9tablir une usine de production de m\u00e9dicaments destin\u00e9s au traitement des maladies oculaires graves, y compris celles li\u00e9es au diab\u00e8te.<\/p>\n<figure class=\"spip-document spip-document-57853 aligncenter\"><img decoding=\"async\" src=\"https:\/\/fr.igihe.com\/IMG\/jpg\/pk_3-27.jpg\" alt=\"Le Gouvernement est en pourparlers avec Pharco Pharmaceuticals, leader \u00e9gyptien de l\u2019industrie pharmaceutique.\" \/><\/figure>\n<figure class=\"spip-document spip-document-57854 aligncenter\"><img decoding=\"async\" src=\"https:\/\/fr.igihe.com\/IMG\/jpg\/rdb-2.jpg\" alt=\"Avant de rencontrer le Pr\u00e9sident Kagame, Dr. Sherine Abbas Helmy et sa d\u00e9l\u00e9gation ont \u00e9chang\u00e9 avec le Directeur G\u00e9n\u00e9ral de l\u2019Agence rwandaise de d\u00e9veloppement.\" \/><\/figure>\n","protected":false},"excerpt":{"rendered":"<p>Le Gouvernement est en pourparlers avec Pharco Pharmaceuticals, leader \u00e9gyptien de l&#8217;industrie pharmaceutique, dans le but de d\u00e9velopper une coop\u00e9ration bilat\u00e9rale et examiner la possibilit\u00e9 de construire une usine de production de m\u00e9dicaments au Rwanda.<\/p>\n","protected":false},"author":488,"featured_media":4000057852,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[7529],"tags":[7605],"byline":[9865],"hashtag":[],"class_list":["post-36782","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-actualite-3","tag-homenews","byline-alain-bertrand-tunezerwe"],"bylines":[{"id":9865,"name":"Alain Bertrand Tunezerwe","slug":"alain-bertrand-tunezerwe","description":"","image":{"id":0,"url":"https:\/\/secure.gravatar.com\/avatar\/?s=96&d=mm&f=y&r=g","alt":"Default avatar","title":"Default avatar","caption":"","mime_type":"image\/jpeg","sizes":[]},"user_id":452}],"contributors":[{"id":9865,"name":"Alain Bertrand Tunezerwe","slug":"alain-bertrand-tunezerwe","description":"","image":{"id":0,"url":"https:\/\/secure.gravatar.com\/avatar\/?s=96&d=mm&f=y&r=g","alt":"Default avatar","title":"Default avatar","caption":"","mime_type":"image\/jpeg","sizes":[]},"user_id":452}],"featured_image":{"id":4000057852,"url":"https:\/\/fr-images.igihe.com\/IMG\/logo\/pk_3_cp.jpg","alt":"","caption":"","mime_type":"image\/jpeg","width":0,"height":0,"sizes":{"thumbnail":{"url":"https:\/\/fr-images.igihe.com\/IMG\/logo\/pk_3_cp.jpg","width":1,"height":1},"medium":{"url":"https:\/\/fr-images.igihe.com\/IMG\/logo\/pk_3_cp.jpg","width":1,"height":1},"medium_large":{"url":"https:\/\/fr-images.igihe.com\/IMG\/logo\/pk_3_cp.jpg","width":1,"height":1},"large":{"url":"https:\/\/fr-images.igihe.com\/IMG\/logo\/pk_3_cp.jpg","width":1,"height":1},"full":{"url":"https:\/\/fr-images.igihe.com\/IMG\/logo\/pk_3_cp.jpg","width":0,"height":0}}},"_links":{"self":[{"href":"https:\/\/new.igihe.com\/french\/wp-json\/wp\/v2\/posts\/36782","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/new.igihe.com\/french\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/new.igihe.com\/french\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/new.igihe.com\/french\/wp-json\/wp\/v2\/users\/488"}],"replies":[{"embeddable":true,"href":"https:\/\/new.igihe.com\/french\/wp-json\/wp\/v2\/comments?post=36782"}],"version-history":[{"count":0,"href":"https:\/\/new.igihe.com\/french\/wp-json\/wp\/v2\/posts\/36782\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/new.igihe.com\/french\/wp-json\/wp\/v2\/media\/4000057852"}],"wp:attachment":[{"href":"https:\/\/new.igihe.com\/french\/wp-json\/wp\/v2\/media?parent=36782"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/new.igihe.com\/french\/wp-json\/wp\/v2\/categories?post=36782"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/new.igihe.com\/french\/wp-json\/wp\/v2\/tags?post=36782"},{"taxonomy":"byline","embeddable":true,"href":"https:\/\/new.igihe.com\/french\/wp-json\/wp\/v2\/byline?post=36782"},{"taxonomy":"hashtag","embeddable":true,"href":"https:\/\/new.igihe.com\/french\/wp-json\/wp\/v2\/hashtag?post=36782"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}